High throughput drug discovery

Small molecules interact with cellular components and thereby influence biological processes. In order to facilitate and accelerate the discovery of bioactive small molecules, an infrastructure for the storage and screening of small molecules was installed at the Compound Management and Screening Center (COMAS). The COMAS is an important mile stone in the Max Planck-Society`s exploitation of Know-How for medical research and the development of new pharmaceutical applications.